AN OPEN-LABEL, MULTICENTER, PHASE I TRIAL EVALUATING THE SAFETY AND PHARMACOKINETICS OF ESCALATING DOSES OF BTCT4465A IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA

Type of Cancer
Lymphoma

Site
Hackensack

Sponsor
Genentech

Protocol Number
Genentech GO29781

To Learn More Call
(201)-510-0950